Cargando…
High levels of macrolide-resistant Mycoplasma genitalium in Queensland, Australia
The macrolide azithromycin is recommended for treatment of Mycoplasma genitalium infection; however, M. genitalium strains possessing macrolide resistance-mediating mutations (MRMMs) are increasingly being reported. Here, we used the SpeeDx ResistancePlus MG kit, which provides simultaneous detectio...
Autores principales: | Trembizki, Ella, Buckley, Cameron, Bletchly, Cheryl, Nimmo, Graeme R., Whiley, David M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Microbiology Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845567/ https://www.ncbi.nlm.nih.gov/pubmed/28893363 http://dx.doi.org/10.1099/jmm.0.000584 |
Ejemplares similares
-
Macrolide Resistance in Mycoplasma genitalium in Singapore
por: Barkham, Timothy, et al.
Publicado: (2017) -
Decreased Neisseria gonorrhoeae genotypic diversity following COVID-19 restrictions in Queensland, Australia 2020
por: Alharbi, Bushra, et al.
Publicado: (2023) -
Exploring the implications for coincidental treatment of Mycoplasma genitalium infection in Neisseriagonorrhoeae-positive patients
por: Mhango, Lebogang P, et al.
Publicado: (2021) -
Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium
por: Murray, Gerald L., et al.
Publicado: (2017) -
Mycoplasma genitalium macrolide and fluoroquinolone resistance in pregnant women in Papua New Guinea
por: Jonduo, Marinjho E, et al.
Publicado: (2023)